Neuromodulation therapies including intrathecal pumps, spinal cord and peripheral nerve stimulators can be excellent choices for patients with cancer-related pain. Improving survival rates and duration of patients with cancer pain are allowing consideration of these therapies more frequently than in the past. Cancer patients are a unique population with some specific needs such as frequent imaging that can impact on the choice for neuromodulation therapies in this group.
Upon completion of this educational activity, participants should be able to:
- Indicate neuromodulation therapies for analgesia for cancer-related pain.
- Discuss implications of indwelling neuromodulation devices for imaging for surveillance for cancer imaging.
- Assess the impact of intrathecal opioid infusions for cancer-related pain on systemic levels of opioids.
- Describe peripheral neuromodulation for cancer pain.
Intrathecal Therapies: What is New for Cancer Pain?
Lisa Stearns, MD
Spinal Cord Stimulation for Cancer Pain: Implications for Cancer Surveillance Imaging
Amitabh Gulati, MD
Peripheral Nerve Stimulation for Cancer Pain
Einar Ottestad, MD
Impact of Intrathecal Opioid Therapy on Serum Opioid Levels and Clinical Outcomes in Cancer Pain
Shane E. Brogan, MB BCh
Faculty and Presentations subject to change.
- Research in Neuromodulation: Trials and Tribulations
- Outcomes and Access to Neuromodulation for Women and Underrepresented Minorities: A Call to Action
- Engineering Principles of DBS and SCS in Clinical Practice: Emerging Concepts
- Open- vs. Closed-Loop Neurostimulation and Enabling Biomarkers
- American Academy of Pain Medicine (AAPM) Session: Integrating Neuromodulation Into Multimodal Pain Care